Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Indie agencies want The Trade Desk and Amazon DSP to acknowledge their buying power with negotiating leverage
Indie agencies say DSP giants block direct seats and fee relief despite spend commitments.
Nearly 30% of holiday budgets expected to be spent by the end of October
Per a new report from Deloitte, 28% of shoppers’ budgets are expected to be exhausted by the end of October.
Apple finally explains its Safari block, and identity companies are in its sights
As Apple spells out its case for blocking identity companies in Safari, its job board shows an ads business with big plans.